Published in Medical Device Law Weekly, January 9th, 2011
The next generation HemiCAP(BIO) implant is providing a biological scaffold with a cell-friendly surface environment that is supported by a stable, contoured implant.
Arthroscopic cartilage procedures have been targeting bone marrow cells for focal cartilage repair for over two decades. "We are excited to combine our focal HemiCAP® resurfacing technology with the cellular healing...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Device Law Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.